Member News Archive - Page 48 of 184 - MassBio

News

BioIVT to Highlight its Expanded ADME-Tox Products and Services Portfolio at the European ISSX and DMDG Meeting

Jun 11, 2023

Posted by BioIVT

News

Epithelial Barrier Theory webinar: registrations are open!

Jun 08, 2023

Posted by Genoskin

News

Azzur Group Names Quality Management Expert, Brian Salbilla, Director of its Chicago-Based GxP Consulting Operation

Jun 08, 2023

News

Introducing MANTIS®: A Breakthrough Analytic Pipeline for Unraveling the Complexity of Inflammatory Skin Conditions

Jun 08, 2023

Posted by Genoskin

News

BioIVT to Host an Advanced In Vitro ADME Strategies Symposium in Copenhagen

Jun 06, 2023

Posted by BioIVT

News

Introduction to SciSafe Inc.

Jun 05, 2023

Posted by SciSafe, Inc.

News

Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator

Jun 02, 2023

Posted by Societal CDMO

News

Societal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of iNexin™

Jun 02, 2023

Posted by Societal CDMO

News

Societal CDMO Signs Multiple Project Expansion Agreements With Existing Customers

Jun 02, 2023

Posted by Societal CDMO

News

Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352

Jun 02, 2023

Posted by Societal CDMO

News

Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia Site

Jun 02, 2023

Posted by Societal CDMO

News

Freshfields Advises SERB Pharmaceuticals on its U.S. Partnership with SFJ Pharmaceuticals

Jun 01, 2023

Posted by Freshfields